Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $497.95 | 37 | 97.1% |
| Education | $14.75 | 4 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $299.85 | 32 | $0 (2022) |
| AbbVie Inc. | $212.85 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $200.18 | 8 | AbbVie Inc. ($200.18) |
| 2022 | $30.95 | 2 | Sunovion Pharmaceuticals Inc. ($18.28) |
| 2021 | $29.27 | 2 | Sunovion Pharmaceuticals Inc. ($29.27) |
| 2020 | $14.18 | 1 | Sunovion Pharmaceuticals Inc. ($14.18) |
| 2019 | $77.72 | 7 | Sunovion Pharmaceuticals Inc. ($77.72) |
| 2018 | $39.07 | 4 | Sunovion Pharmaceuticals Inc. ($39.07) |
| 2017 | $121.33 | 17 | Sunovion Pharmaceuticals Inc. ($121.33) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CNS | ||||||
| 10/01/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: CNS | ||||||
| 06/17/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: CNS | ||||||
| 09/09/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: CNS | ||||||
| 11/27/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: CNS | ||||||
| 10/30/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: CNS | ||||||
| 10/03/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: CNS | ||||||
| 09/05/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: CNS | ||||||
| 06/07/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: CNS | ||||||
| 02/07/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: CNS | ||||||
| 01/24/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: CNS | ||||||
| 11/21/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: CNS | ||||||
| 10/17/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: CNS | ||||||
| 09/28/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: CNS | ||||||
| 08/17/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: CNS | ||||||
| 10/05/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 47 | 118 | $17,110 | $5,542 |
| 2022 | 2 | 53 | 113 | $16,385 | $4,338 |
| 2021 | 2 | 63 | 150 | $21,750 | $6,133 |
| 2020 | 4 | 115 | 207 | $21,545 | $6,784 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 29 | 86 | $12,470 | $3,194 | 25.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 18 | 32 | $4,640 | $2,348 | 50.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 37 | 94 | $13,630 | $3,480 | 25.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 16 | 19 | $2,755 | $857.59 | 31.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 40 | 109 | $15,805 | $3,792 | 24.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 23 | 41 | $5,945 | $2,341 | 39.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 39 | 66 | $4,625 | $2,353 | 50.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 44 | 90 | $13,050 | $2,221 | 17.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 15 | 29 | $2,000 | $1,261 | 63.1% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 17 | 22 | $1,870 | $948.80 | 50.7% |
About Dr. Kang Yu, MD
Dr. Kang Yu, MD is a Psychiatry healthcare provider based in Seneca Falls, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346354800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kang Yu, MD has received a total of $512.70 in payments from pharmaceutical and medical device companies, with $200.18 received in 2023. These payments were reported across 41 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($497.95).
As a Medicare-enrolled provider, Yu has provided services to 278 Medicare beneficiaries, totaling 588 services with total Medicare billing of $22,797. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Seneca Falls, NY
- Active Since 08/19/2006
- Last Updated 10/30/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1346354800
Products in Payments
- LATUDA (Drug) $299.85
- VRAYLAR (Drug) $212.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.